APA (7th ed.) Citation

PhD, B. L., MD, X. T., MS, Y. Z., MS, X. H., MD, H. Z., MS, H. X., . . . BS, K. Z. Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study. SAGE Publishing.

Chicago Style (17th ed.) Citation

PhD, Bingqing Luo, Xiaoyan Tan MD, Yanfang Zhang MS, Xiao Hu MS, Hanqing Zeng MD, Hongbo Xiao MS, Shifeng Lou BS, and Kang Zhou BS. Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study. SAGE Publishing.

MLA (9th ed.) Citation

PhD, Bingqing Luo, et al. Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study. SAGE Publishing.